Officer Dennis Mulroy Files to Sell Additional $594K in Stock, Continuing Recent Sales Trend
ANAB has more than doubled off its 52-week low of $11.402.
Summary
AnaptysBio officer Dennis Mulroy has filed a Form 144 indicating intent to sell an additional $594,671 in company stock, adding to a pattern of recent insider sales.
Key Events · Ownership and Investor Activity · ANAB
-
Proposed Stock Sale
Officer Dennis Mulroy intends to sell 10,264 shares of common stock, valued at approximately $594,671, with an approximate sale date of May 28, 2026.
-
Ongoing Insider Distribution
This filing follows previous sales by Dennis Mulroy, totaling 65,467 shares for gross proceeds of $3,913,629 over the past three months, indicating a continued trend of insider distribution.
-
Officer Selling
The filer, Dennis Mulroy, is an officer of AnaptysBio, making the sale a notable insider transaction that contributes to the overall insider selling trend.
Analysis · ANAB · Life Sciences
This Form 144 filing indicates an officer's intent to sell a significant amount of company stock, which adds to a pattern of insider distribution observed over the last 90 days. While the individual proposed sale is a small percentage of the company's market cap, the cumulative sales by this officer, totaling nearly $4 million in the past three months, represent a consistent reduction in insider holdings. This ongoing selling pressure from an officer could be interpreted negatively by investors, especially following the company's recent spin-off and share repurchase program announcement.
At the time of this filing, ANAB was trading at $57.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.